Clinical trial Recruiting at 1 site Interventional Ages 13 to 17

Sleep behavioral program for adolescents with overweight or obesity

Official title: Treatment of Overweight and Obesity in Adolescents - Impact of a Sleep Behavioral Intervention - SLEEP-OB

Run by University of Beira Interior · NCT07255274 · Data updated 2026-11-12

This trial will test whether adding a sleep-focused behavioral program to usual weight treatment helps teens (13–17) with overweight or obesity who have poor sleep improve body composition and health markers.

Quick facts

Study typeInterventional
Ages13 Years to 17 Years
SexAll
Enrollment126 (estimated)
SponsorUniversity of Beira Interior
Academic / other
Locations2 sites (Covilha and 1 other locations)
StatusRecruiting
StartedJune 3, 2025
Main results expectedJune 2026
Study endsDecember 2026
Registry record updatedDecember 1, 2025
Trial IDNCT07255274 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 13–17 with overweight or obesity by WHO BMI z-score criteria who report poor sleep quality and whose guardians provide consent are the intended participants.

Probably not a fit

Those with secondary causes of obesity, major psychiatric or neurological disorders affecting sleep, or who are taking SSRIs or other medications that affect sleep are excluded and unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, open-label behavioral trial at two Portuguese sites that will enroll 126 adolescents (ages 13–17) with overweight or obesity and poor sleep quality. Participants are randomly assigned to receive seven CBT-based sleep sessions over six months plus standard multicomponent obesity treatment, or standard treatment alone. Primary outcomes focus on adiposity (BMI z-score, fat mass percentage, fat-free mass index), with secondary outcomes including cardiometabolic risk, objective sleep measures (actigraphy and level 3 ambulatory study), eating patterns, physical activity, emotional well-being, quality of life, and metabolic hormones. Blood samples will be collected at baseline, 6 months, and 12 months, and some samples will be stored for additional analyses.

Why it matters

Potential benefit: If effective, adding a sleep behavioral program could improve body composition and reduce cardiometabolic risk in adolescents with overweight or obesity.

How similar studies have gone: Some prior small studies have suggested sleep interventions may help weight-related outcomes in youth, but results are mixed and methodological differences limit definitive conclusions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Informed consent from legal guardians and assent/consent from the adolescent;
2. Age between 13 and 17 years at the time of consent;
3. Diagnosis of overweight (BMI z-score \> 1 and ≤ 2) or obesity (BMI z-score \> 2), according to WHO criteria;
4. Sleep deprivation or poor sleep quality, based on the initial screening questionnaire.

Exclusion Criteria:

1. Secondary obesity (e.g., hypothalamic, genetic, or endocrine causes);
2. Comorbid psychiatric or neurological disorders (e.g., epilepsy, autism spectrum disorder) that affect sleep;
3. Current treatment with selective serotonin reuptake inhibitors (SSRIs) or other medications affecting sleep.

Where it's running

  • Unidade Local de Saúde Cova da Beira
    Covilha, Portugal
    Recruiting
  • Hospital CUF Porto
    Porto, Portugal
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Tegileridine for pain after bariatric surgery

    This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.

    Recruiting Phase 3 The First Hospital of Jilin University · Changchun, Jilin · NCT07844512

  • IBI3046 in Overweight or Obesity

    This study tests how safe and tolerable IBI3046 is in adults with overweight or obesity in China.

    Recruiting Phase 1 Innovent Biologics (Suzhou) Co. Ltd. · Beijing, Beijing Municipality · NCT07809945

  • Yoga to reduce stress and improve sleep and sexual quality of life during pregnancy

    We will try a researcher-led yoga program with pregnant women in their third trimester to see if it lowers stress, improves sleep, and boosts sexual quality of life.

    Recruiting Amasya University · Amasya · NCT07485790

  • Targeted sleep care during tobacco or cannabis quitting

    This pilot will test whether systematically screening for and treating sleep problems during quitting programs helps adults stopping tobacco or cannabis stay abstinent longer.

    Recruiting Centre Hospitalier St Anne · Paris, Île-de-France Region · NCT07202351

  • Robotic versus laparoscopic conversion to RYGB for revision bariatric surgery

    We will see if robotic surgery or laparoscopy leads to fewer postoperative complications for people having revision bariatric surgery converted to RYGB.

    Recruiting GCS Ramsay Santé pour l'Enseignement et la Recherche · Lyon and 1 other locations · NCT07180316

  • Bone health, vitamin D, weight, and fractures in children

    See if blood markers (alkaline phosphatase, calcium, PTH, vitamin D), body weight, and calcium intake are linked to fractures in children aged 3–15 after low-energy trauma.

    Recruiting at 2 sites Paracelsus Medical University · Brixen, Bolzano and 1 other locations · NCT07143552

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.